HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $36,461 | -65.3% | 45,014 | -42.4% | 0.00% | – |
| Q3 2022 | $105,000 | -48.5% | 78,164 | -37.2% | 0.00% | – |
| Q2 2022 | $204,000 | -37.0% | 124,511 | -12.3% | 0.00% | – |
| Q1 2022 | $324,000 | +295.1% | 142,000 | +303.9% | 0.00% | – |
| Q4 2021 | $82,000 | -89.1% | 35,158 | -72.6% | 0.00% | – |
| Q3 2021 | $755,000 | -42.6% | 128,313 | -10.6% | 0.00% | – |
| Q2 2021 | $1,315,000 | +35.0% | 143,539 | +98.1% | 0.00% | – |
| Q1 2021 | $974,000 | -56.4% | 72,441 | -64.1% | 0.00% | – |
| Q4 2020 | $2,234,000 | +630.1% | 201,540 | +522.5% | 0.00% | – |
| Q3 2020 | $306,000 | – | 32,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |